533 related articles for article (PubMed ID: 26700706)
1. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
[TBL] [Abstract][Full Text] [Related]
2. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
3. 5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost.
Gupta A; Khan AJ; Yegya-Raman N; Sayan M; Ahlawat S; Ohri N; Goyal S; Moore DF; Eladoumikdachi F; Toppmeyer D; Haffty BG
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):267-274. PubMed ID: 31175905
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial.
Khan AJ; Poppe MM; Goyal S; Kokeny KE; Kearney T; Kirstein L; Toppmeyer D; Moore DF; Chen C; Gaffney DK; Haffty BG
J Clin Oncol; 2017 Jun; 35(18):2037-2043. PubMed ID: 28459606
[TBL] [Abstract][Full Text] [Related]
5. Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.
Manning MA; Arthur DW; Schmidt-Ullrich RK; Arnfield MR; Amir C; Zwicker RD
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1301-6. PubMed ID: 11121626
[TBL] [Abstract][Full Text] [Related]
6. Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer.
Kim JY; Jung SY; Lee S; Kang HS; Lee ES; Park IH; Lee KS; Ro J; Lee NK; Shin KH
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1037-42. PubMed ID: 24267970
[TBL] [Abstract][Full Text] [Related]
7. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
Yadav BS; Sharma SC; Singh G; Dahiya D
J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
[TBL] [Abstract][Full Text] [Related]
9. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
10. Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost.
Chadha M; Woode R; Sillanpaa J; Lucido D; Boolbol SK; Kirstein L; Osborne MP; Feldman S; Harrison LB
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):40-4. PubMed ID: 23290443
[TBL] [Abstract][Full Text] [Related]
11. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.
Whelan TJ; Julian JA; Berrang TS; Kim DH; Germain I; Nichol AM; Akra M; Lavertu S; Germain F; Fyles A; Trotter T; Perera FE; Balkwill S; Chafe S; McGowan T; Muanza T; Beckham WA; Chua BH; Gu CS; Levine MN; Olivotto IA;
Lancet; 2019 Dec; 394(10215):2165-2172. PubMed ID: 31813635
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated boost after whole breast irradiation in breast carcinoma: chronic toxicity results and cosmesis.
Sanz J; Rodríguez N; Foro P; Dengra J; Reig A; Pérez P; Membrive I; Ortiz A; Codinach M; Algara M
Clin Transl Oncol; 2017 Apr; 19(4):464-469. PubMed ID: 27655367
[TBL] [Abstract][Full Text] [Related]
13. Prone breast intensity modulated radiation therapy: 5-year results.
Osa EO; DeWyngaert K; Roses D; Speyer J; Guth A; Axelrod D; Fenton Kerimian M; Goldberg JD; Formenti SC
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):899-906. PubMed ID: 24867535
[TBL] [Abstract][Full Text] [Related]
14. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
Offersen BV; Alsner J; Nielsen HM; Jakobsen EH; Nielsen MH; Krause M; Stenbygaard L; Mjaaland I; Schreiber A; Kasti UM; Overgaard J;
J Clin Oncol; 2020 Nov; 38(31):3615-3625. PubMed ID: 32910709
[TBL] [Abstract][Full Text] [Related]
16. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM;
Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196
[TBL] [Abstract][Full Text] [Related]
17. International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.
Olivotto IA; Link E; Phillips C; Whelan TJ; Bryant G; Kunkler IH; Westenberg AH; Purohit K; Ahern V; Graham PH; Akra M; McArdle O; Ludbrook JJ; Harvey JA; Maduro JH; Kirkove C; Gruber G; Martin JD; Campbell ID; Delaney GP; Chua BH;
Radiother Oncol; 2020 Jan; 142():180-185. PubMed ID: 31431385
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
19. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
Harms W; Krempien R; Hensley FW; Berns C; Fritz P; Wannenmacher M
Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern India.
Nandi M; Mahata A; Mallick I; Achari R; Chatterjee S
Asian Pac J Cancer Prev; 2014; 15(6):2505-10. PubMed ID: 24761855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
